STOCK TITAN

Ameriprise (NYSE: AMP) prices 4.800% 2031 and 5.350% 2036 senior notes

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Ameriprise Financial, Inc. issued $300,000,000 of 4.800% Senior Notes due 2031 and $450,000,000 of 5.350% Senior Notes due 2036. These notes were sold to underwriters led by BofA Securities, Citigroup Global Markets, and J.P. Morgan Securities under an underwriting agreement dated June 4, 2026.

The notes were offered using a prospectus supplement dated June 4, 2026 to a February 23, 2024 prospectus, both under the company’s shelf registration statement on Form S-3. Related documents, including the forms of the notes, the underwriting agreement, and a legal opinion from Faegre Drinker Biddle & Reath LLP, were filed as exhibits.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
2031 Senior Notes $300,000,000 principal, 4.800% coupon 4.800% Senior Notes due 2031 issued June 9, 2026
2036 Senior Notes $450,000,000 principal, 5.350% coupon 5.350% Senior Notes due 2036 issued June 9, 2026
Shelf registration Form S-3, No. 333-277307 Prospectus dated February 23, 2024
Prospectus supplement date June 4, 2026 Supplement governing the notes offering
Senior Notes financial
"4.800% Senior Notes due 2031 and 5.350% Senior Notes due 2036"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
Underwriting Agreement financial
"sold pursuant to the Underwriting Agreement that the Company entered into on June 4, 2026"
An underwriting agreement is a contract where a company selling new stocks or bonds hires financial firms to buy those securities and resell them to investors. It matters because the agreement sets the offering price, number of securities, fees and which party bears the risk if sales fall short—think of it as a promise that the sale will happen and a roadmap investors can use to understand how the new securities reach the market.
prospectus supplement regulatory
"offered pursuant to the prospectus supplement dated June 4, 2026, to the prospectus dated February 23, 2024"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
registration statement on Form S-3 regulatory
"filed with the Securities and Exchange Commission as part of the Company’s registration statement on Form S-3"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
aggregate principal amount financial
"issued $300,000,000 aggregate principal amount of its 4.800% Senior Notes"
The aggregate principal amount is the total amount of money borrowed through a bond or loan that the borrower promises to repay. It’s like the original price tag on a loan or bond, showing how much money is involved in the deal. This number matters because it indicates the size of the debt and helps investors understand the scale of the borrowing.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0000820027 AMERIPRISE FINANCIAL INC 0000820027 2026-06-04 2026-06-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

  

FORM 8-K

 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 4, 2026

 

AMERIPRISE FINANCIAL, INC.
(Exact name of registrant as specified in its charter)
 
Delaware   001-32525   13-3180631
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1099 Ameriprise Financial Center

Minneapolis, Minnesota

  55474
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (612) 671-3131

 

Former name or former address, if changed since last report: Not Applicable

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol
  Name of each exchange on which registered
Common Stock (par value $.01 per share)   AMP   The New York Stock Exchange, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 8.01Other Events.

 

On June 9, 2026, Ameriprise Financial, Inc. (the “Company”) issued $300,000,000 aggregate principal amount of its 4.800% Senior Notes due 2031 (the “2031 Notes”) and $450,000,000 aggregate principal amount of its 5.350% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes, the “Notes”). The Notes were sold pursuant to the Underwriting Agreement (the “Underwriting Agreement”) that the Company entered into on June 4, 2026 with BofA Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein (collectively, the “Underwriters”). The Notes were offered pursuant to the prospectus supplement dated June 4, 2026, to the prospectus dated February 23, 2024, each filed with the Securities and Exchange Commission (the “Commission”) as part of the Company’s registration statement on Form S-3 (Registration No. 333-277307) (the “Registration Statement”).

 

The following documents relating to the Notes are filed herewith as exhibits and incorporated by reference into this Form 8-K and the Registration Statement: (i) the Underwriting Agreement, (ii) the forms of the Notes and (iii) the opinion of Faegre Drinker Biddle & Reath LLP.

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
Exhibit 1.1   Underwriting Agreement, dated June 4, 2026, among the Company and BofA Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters.
     
Exhibit 4.1   Form of 4.800% Senior Note due 2031.
     
Exhibit 4.2   Form of 5.350% Senior Note due 2036.
     
Exhibit 5.1   Opinion of Faegre Drinker Biddle & Reath LLP.
     
Exhibit 23.1   Consent of Faegre Drinker Biddle & Reath LLP. (included as part of Exhibit 5.1).
     
Exhibit 104   Cover page (embedded within the Inline eXtensible Business Reporting Language)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AMERIPRISE FINANCIAL, INC.
(Registrant)
 
Date: June 9, 2026 By: /s/ Shweta Jhanji
  Name: Shweta Jhanji
  Title: Senior Vice President and Treasurer

 

 

 

FAQ

What did Ameriprise Financial (AMP) disclose in this Form 8-K?

Ameriprise Financial disclosed it issued two new series of senior notes: $300,000,000 of 4.800% notes due 2031 and $450,000,000 of 5.350% notes due 2036, sold through a syndicate of underwriters under a June 4, 2026 underwriting agreement.

What are the key terms of Ameriprise Financial’s 4.800% Senior Notes due 2031?

The 2031 notes have an aggregate principal amount of $300,000,000 and a 4.800% interest rate. They are senior unsecured obligations of Ameriprise Financial, issued on June 9, 2026, and offered under a prospectus supplement tied to the company’s Form S-3 shelf registration statement.

What are the key terms of Ameriprise Financial’s 5.350% Senior Notes due 2036?

The 2036 notes have an aggregate principal amount of $450,000,000 and a 5.350% interest rate. They are senior obligations due in 2036, issued on June 9, 2026, and were offered under a June 4, 2026 prospectus supplement to Ameriprise’s existing Form S-3 registration.

Which underwriters handled Ameriprise Financial’s new senior notes offering?

BofA Securities, Inc., Citigroup Global Markets Inc., and J.P. Morgan Securities LLC acted as representatives of the several underwriters. Ameriprise entered into an underwriting agreement with them on June 4, 2026 covering the sale of both the 2031 and 2036 senior notes.

Under what SEC registration did Ameriprise Financial offer these senior notes?

The notes were offered under Ameriprise Financial’s shelf registration statement on Form S-3, Registration No. 333-277307. A prospectus dated February 23, 2024 and a prospectus supplement dated June 4, 2026 were filed with the SEC in connection with this offering.

Filing Exhibits & Attachments

7 documents